Kingfish Holding Corp

2024 Q1 Form 10-Q Financial Statement

#000147793224000736 Filed on February 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $19.00 $1.395K $46.61K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $19.00 $1.395K $46.61K
YoY Change -99.86% -97.01% 214.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $94.16K $94.16K $94.18K
YoY Change -0.02% -0.02% -14.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $879.4K $639.4K $215.1K
YoY Change 151.42% 197.21% -3.01%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $20.00K $220.0K $400.0K
YoY Change -92.59% -45.0% 166.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $879.4K $639.4K $215.1K
Total Long-Term Liabilities $20.00K $220.0K $400.0K
Total Liabilities $899.4K $859.4K $615.1K
YoY Change 45.12% 39.71% 65.44%
SHAREHOLDERS EQUITY
Retained Earnings -$5.270M -$5.228M -$4.939M
YoY Change 5.9% 5.86% 4.48%
Common Stock $24.00 $12.09K $12.09K
YoY Change -99.8% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$899.4K -$858.0K -$568.5K
YoY Change
Total Liabilities & Shareholders Equity $19.00 $1.395K $46.61K
YoY Change -99.86% -97.01% 214.06%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-857974 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-524191 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-857974 usd
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001374881
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120942987 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120942987 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120942987 shares
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
000-52375
CY2023Q4 dei Entity Registrant Name
EntityRegistrantName
Kingfish Holding Corporation
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4838580
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
822 62nd Street Circle East
CY2023Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 105
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Bradenton
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34208
CY2023Q4 dei City Area Code
CityAreaCode
941
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
487-3653
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
true
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
120942987 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395 usd
CY2023Q4 us-gaap Assets
Assets
1395 usd
CY2023Q3 us-gaap Assets
Assets
1395 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
94156 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
94156 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
49694 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
45019 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
90000 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
90000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
180000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
130000 usd
CY2023Q4 king Advances From Related Party
AdvancesFromRelatedParty
225519 usd
CY2023Q3 king Advances From Related Party
AdvancesFromRelatedParty
173714 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
639369 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
532889 usd
CY2023Q4 king Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
200000 usd
CY2023Q3 king Notes Payable Related Party Noncurrent
NotesPayableRelatedPartyNoncurrent
250000 usd
CY2023Q4 us-gaap Decommissioning Liability Noncurrent
DecommissioningLiabilityNoncurrent
20000 usd
CY2023Q3 us-gaap Decommissioning Liability Noncurrent
DecommissioningLiabilityNoncurrent
20000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
220000 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
270000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
859369 usd
CY2023Q3 us-gaap Liabilities
Liabilities
802889 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
12094 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
12094 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4378213 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4378213 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5228281 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5171801 usd
CY2023Q4 king Rescission Liabilities
RescissionLiabilities
-20000 usd
CY2023Q3 king Rescission Liabilities
RescissionLiabilities
-20000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-801494 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1395 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1395 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
51805 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
40447 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
51805 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
40515 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
4675 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
3810 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4675 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3810 usd
CY2023Q4 king Total Operating And Other Expenses
TotalOperatingAndOtherExpenses
56480 usd
CY2022Q4 king Total Operating And Other Expenses
TotalOperatingAndOtherExpenses
44325 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56480 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44325 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-56480 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-44325 usd
CY2023Q4 king Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2022Q4 king Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.00
CY2023Q4 king Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
120942987 shares
CY2022Q4 king Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
120942987 shares
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-44325 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-568516 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-801494 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-56480 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-56480 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-44325 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4675 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3809 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
0 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-113124 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51805 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-153640 usd
CY2023Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
51805 usd
CY2022Q4 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2023Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51805 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
200000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
46360 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1395 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46606 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities, if any at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</p>
CY2023Q4 king Retained Earnings Accumulated Deficits
RetainedEarningsAccumulatedDeficits
-5228281 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares

Files In Submission

Name View Source Status
0001477932-24-000736-index-headers.html Edgar Link pending
0001477932-24-000736-index.html Edgar Link pending
0001477932-24-000736.txt Edgar Link pending
0001477932-24-000736-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
king-20231231.xsd Edgar Link pending
king_10q.htm Edgar Link pending
king_ex311.htm Edgar Link pending
king_ex312.htm Edgar Link pending
king_ex321.htm Edgar Link pending
king_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
king-20231231_cal.xml Edgar Link unprocessable
king-20231231_def.xml Edgar Link unprocessable
king-20231231_lab.xml Edgar Link unprocessable
king-20231231_pre.xml Edgar Link unprocessable
king_10q_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending